-
Sartorius Completes Acquisition of Novasep’s Chromatography Equipment Division
AmericanPharmaceuticalReview
February 10, 2022
Novasep, a supplier of services and technologies for the life sciences industry, and Sartorius Stedim Biotech, a subgroup of the life science company Sartorius...
-
Sartorius Completes Acquisition of Novasep's Chromatography Biz
contractpharma
February 08, 2022
For the Bioprocess Solutions Division, the company now forecasts sales revenue growth of about 17 to 21 percent for 2022.
-
Novasep, Exelixis Ink ADC Manufacturing Agreement
contractpharma
July 07, 2021
Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.
-
Novasep Upgrades API Manufacturing Facility
contractpharma
June 28, 2021
Novasep, a supplier of services and technologies for the life sciences industry, is investing $7.3 million at its Mourenx site in France to modernize the API manufacturing facility.
-
Novasep Expands HPAPI Manufacturing Capacity
contractpharma
May 14, 2021
Novasep has expanded its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing capabilities on its Le Mans, France site.
-
Thermo Fisher Scientific acquires Henogen, viral vector manufacturing business from Novasep
expresspharma
January 18, 2021
The business will be part of the Pharma Services business within the Laboratory Products and Services Segment.
-
Sartorius to Acquire Novasep's Chromatography Biz
contractpharma
January 07, 2021
Novasep's division expects to generate sales of approximately €37 million in 2020 with double-digit profit margins.
-
Sensorion and Novasep Sign Agreement
contractpharma
November 06, 2020
Covers the development and manufacturing of AAV vectors, a key step for Sensorion’s gene therapy programs.
-
Novasep, Lysogene Enter Gene Therapy Collaboration
contractpharma
May 28, 2020
Novasep and Lysogene have entered an agreement for the development and manufacturing of LYS-GM101, an AAVrh10-based gene therapy drug candidate for the treatment of GM1 gangliosidosis, a rare neuronopathic lysosomal storage disorder.
-
Sartorius Stedim, Novasep to develop novel systems for membrane chromatography
biospectrumasia
March 06, 2019
Sartorius Stedim Biotech (SSB), a leading supplier for the biopharmaceutical industry, and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing.